Allianz Asset Management Gmb H Alkermes Plc. Transaction History
Allianz Asset Management Gmb H
- $72.3 Billion
- Q4 2024
A detailed history of Allianz Asset Management Gmb H transactions in Alkermes Plc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 32,300 shares of ALKS stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,300
Previous 32,300
-0.0%
Holding current value
$1.16 Million
Previous $904,000
2.65%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ALKS
# of Institutions
374Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$664 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$440 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$316 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$271 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.9B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...